Bionet
BIONET Corp. engages in the cell therapy business in Taiwan and internationally. The company offers stem cell banking services, such as stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC and immune cells; and genetic testing services. It also provides storage and application of hematopoietic stem cells; regenerative medicine, analytical testing… Read more
Bionet (1784) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.038x
Based on the latest financial reports, Bionet (1784) has a cash flow conversion efficiency ratio of 0.038x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$85.64 Million) by net assets (NT$2.24 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bionet - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Bionet's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bionet Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bionet ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tavia Acquisition Corp. Unit
NASDAQ:TAVIU
|
-0.001x |
|
Namchow Chemical Industrial Co Ltd
TW:1702
|
-0.027x |
|
Salmones Camanchaca S.A
SN:SALMOCAM
|
-0.019x |
|
RADIANCE HLDGS GRP.HD-01
F:RDH
|
N/A |
|
LIMES SCHLOSSKLINIK. O.N.
F:LIK
|
N/A |
|
Kuvva Gida Ticaret ve Sanayi Yatirimlari A.S.
IS:KUVVA
|
-0.126x |
|
Hansae Co
KO:105630
|
0.138x |
|
Nongshim Holdi
KO:072710
|
0.015x |
Annual Cash Flow Conversion Efficiency for Bionet (2017–2024)
The table below shows the annual cash flow conversion efficiency of Bionet from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$2.40 Billion | NT$176.49 Million | 0.074x | -17.13% |
| 2023-12-31 | NT$1.72 Billion | NT$153.09 Million | 0.089x | +24.41% |
| 2022-12-31 | NT$1.32 Billion | NT$94.65 Million | 0.071x | +577.37% |
| 2021-12-31 | NT$1.32 Billion | NT$13.88 Million | 0.011x | -81.54% |
| 2020-12-31 | NT$1.29 Billion | NT$73.66 Million | 0.057x | +2698.56% |
| 2019-12-31 | NT$1.31 Billion | NT$2.67 Million | 0.002x | +121.09% |
| 2018-12-31 | NT$1.34 Billion | NT$-12.97 Million | -0.010x | +46.69% |
| 2017-12-31 | NT$1.37 Billion | NT$-24.91 Million | -0.018x | -- |